Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition

ABSTRACT Pediatric obesity remains a public health burden and continues to increase in prevalence. The gut microbiota plays a causal role in obesity and is a promising therapeutic target. Specifically, the microbial production of short-chain fatty acids (SCFA) from the fermentation of otherwise indi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zachary C. Holmes, Justin D. Silverman, Holly K. Dressman, Zhengzheng Wei, Eric P. Dallow, Sarah C. Armstrong, Patrick C. Seed, John F. Rawls, Lawrence A. David
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/85d38bebeb3043c59d35049f04fcbb2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:85d38bebeb3043c59d35049f04fcbb2b
record_format dspace
spelling oai:doaj.org-article:85d38bebeb3043c59d35049f04fcbb2b2021-11-15T15:56:43ZShort-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition10.1128/mBio.00914-202150-7511https://doaj.org/article/85d38bebeb3043c59d35049f04fcbb2b2020-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00914-20https://doaj.org/toc/2150-7511ABSTRACT Pediatric obesity remains a public health burden and continues to increase in prevalence. The gut microbiota plays a causal role in obesity and is a promising therapeutic target. Specifically, the microbial production of short-chain fatty acids (SCFA) from the fermentation of otherwise indigestible dietary carbohydrates may protect against pediatric obesity and metabolic syndrome. Still, it has not been demonstrated that therapies involving microbiota-targeting carbohydrates, known as prebiotics, will enhance gut bacterial SCFA production in children and adolescents with obesity (age, 10 to 18 years old). Here, we used an in vitro system to examine the SCFA production by fecal microbiota from 17 children with obesity when exposed to five different commercially available over-the-counter (OTC) prebiotic supplements. We found microbiota from all 17 patients actively metabolized most prebiotics. Still, supplements varied in their acidogenic potential. Significant interdonor variation also existed in SCFA production, which 16S rRNA sequencing supported as being associated with differences in the host microbiota composition. Last, we found that neither fecal SCFA concentration, microbiota SCFA production capacity, nor markers of obesity positively correlated with one another. Together, these in vitro findings suggest the hypothesis that OTC prebiotic supplements may be unequal in their ability to stimulate SCFA production in children and adolescents with obesity and that the most acidogenic prebiotic may differ across individuals. IMPORTANCE Pediatric obesity remains a major public health problem in the United States, where 17% of children and adolescents are obese, and rates of pediatric “severe obesity” are increasing. Children and adolescents with obesity face higher health risks, and noninvasive therapies for pediatric obesity often have limited success. The human gut microbiome has been implicated in adult obesity, and microbiota-directed therapies can aid weight loss in adults with obesity. However, less is known about the microbiome in pediatric obesity, and microbiota-directed therapies are understudied in children and adolescents. Our research has two important findings: (i) dietary prebiotics (fiber) result in the microbiota from adolescents with obesity producing more SCFA, and (ii) the effectiveness of each prebiotic is donor dependent. Together, these findings suggest that prebiotic supplements could help children and adolescents with obesity, but that these therapies may not be “one size fits all.”Zachary C. HolmesJustin D. SilvermanHolly K. DressmanZhengzheng WeiEric P. DallowSarah C. ArmstrongPatrick C. SeedJohn F. RawlsLawrence A. DavidAmerican Society for Microbiologyarticlefermentationmicrobiomepediatric obesityprebioticsshort-chain fatty acidsMicrobiologyQR1-502ENmBio, Vol 11, Iss 4 (2020)
institution DOAJ
collection DOAJ
language EN
topic fermentation
microbiome
pediatric obesity
prebiotics
short-chain fatty acids
Microbiology
QR1-502
spellingShingle fermentation
microbiome
pediatric obesity
prebiotics
short-chain fatty acids
Microbiology
QR1-502
Zachary C. Holmes
Justin D. Silverman
Holly K. Dressman
Zhengzheng Wei
Eric P. Dallow
Sarah C. Armstrong
Patrick C. Seed
John F. Rawls
Lawrence A. David
Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition
description ABSTRACT Pediatric obesity remains a public health burden and continues to increase in prevalence. The gut microbiota plays a causal role in obesity and is a promising therapeutic target. Specifically, the microbial production of short-chain fatty acids (SCFA) from the fermentation of otherwise indigestible dietary carbohydrates may protect against pediatric obesity and metabolic syndrome. Still, it has not been demonstrated that therapies involving microbiota-targeting carbohydrates, known as prebiotics, will enhance gut bacterial SCFA production in children and adolescents with obesity (age, 10 to 18 years old). Here, we used an in vitro system to examine the SCFA production by fecal microbiota from 17 children with obesity when exposed to five different commercially available over-the-counter (OTC) prebiotic supplements. We found microbiota from all 17 patients actively metabolized most prebiotics. Still, supplements varied in their acidogenic potential. Significant interdonor variation also existed in SCFA production, which 16S rRNA sequencing supported as being associated with differences in the host microbiota composition. Last, we found that neither fecal SCFA concentration, microbiota SCFA production capacity, nor markers of obesity positively correlated with one another. Together, these in vitro findings suggest the hypothesis that OTC prebiotic supplements may be unequal in their ability to stimulate SCFA production in children and adolescents with obesity and that the most acidogenic prebiotic may differ across individuals. IMPORTANCE Pediatric obesity remains a major public health problem in the United States, where 17% of children and adolescents are obese, and rates of pediatric “severe obesity” are increasing. Children and adolescents with obesity face higher health risks, and noninvasive therapies for pediatric obesity often have limited success. The human gut microbiome has been implicated in adult obesity, and microbiota-directed therapies can aid weight loss in adults with obesity. However, less is known about the microbiome in pediatric obesity, and microbiota-directed therapies are understudied in children and adolescents. Our research has two important findings: (i) dietary prebiotics (fiber) result in the microbiota from adolescents with obesity producing more SCFA, and (ii) the effectiveness of each prebiotic is donor dependent. Together, these findings suggest that prebiotic supplements could help children and adolescents with obesity, but that these therapies may not be “one size fits all.”
format article
author Zachary C. Holmes
Justin D. Silverman
Holly K. Dressman
Zhengzheng Wei
Eric P. Dallow
Sarah C. Armstrong
Patrick C. Seed
John F. Rawls
Lawrence A. David
author_facet Zachary C. Holmes
Justin D. Silverman
Holly K. Dressman
Zhengzheng Wei
Eric P. Dallow
Sarah C. Armstrong
Patrick C. Seed
John F. Rawls
Lawrence A. David
author_sort Zachary C. Holmes
title Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition
title_short Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition
title_full Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition
title_fullStr Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition
title_full_unstemmed Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition
title_sort short-chain fatty acid production by gut microbiota from children with obesity differs according to prebiotic choice and bacterial community composition
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/85d38bebeb3043c59d35049f04fcbb2b
work_keys_str_mv AT zacharycholmes shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT justindsilverman shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT hollykdressman shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT zhengzhengwei shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT ericpdallow shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT sarahcarmstrong shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT patrickcseed shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT johnfrawls shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
AT lawrenceadavid shortchainfattyacidproductionbygutmicrobiotafromchildrenwithobesitydiffersaccordingtoprebioticchoiceandbacterialcommunitycomposition
_version_ 1718427101510500352